Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Carlo Lucioni
Vaccinating Italian Infants With a New Multicomponent Vaccine (Bexsero®) Against Meningococcal B Disease: A Cost-Effectiveness Analysis
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
A Multinational Economic Evaluation of rhDNase in the Treatment of Cystic Fibrosis
International Journal of Technology Assessment in Health Care
Health Policy
Related publications
News on Vaccines Against Meningococcal Disease. Vaccine Bexsero
Hygiena
Environmental
Public Health
Occupational Health
Potential Benefits of Using a Multicomponent Vaccine for Prevention of Serogroup B Meningococcal Disease
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
The New Multicomponent Vaccine Against Meningococcal Serogroup B, 4CMenB: Immunological, Functional and Structural Characterization of the Antigens
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Pin103 - A Systematic Review: Cost-Effectiveness of Vaccination With New Meningococcal Serogroup B Vaccines
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Should College Students Be Vaccinated Against Meningococcal Disease? A Cost-Benefit Analysis.
American Journal of Public Health
Environmental
Public Health
Occupational Health
A Critical Review of Cost-Effectiveness Analyses of Vaccinating Males Against Human Papillomavirus
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences With Other European Countries
PLoS ONE
Multidisciplinary
Predicted Strain Coverage of a Meningococcal Multicomponent Vaccine (4CMenB) in Portugal
PLoS ONE
Multidisciplinary
Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds With the 13-Valent Pneumococcal Conjugate Vaccine in England
PLoS ONE
Multidisciplinary